Invesco Ltd. - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 187 filers reported holding CARA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$44,355
-34.6%
26,402
+10.2%
0.00%
Q2 2023$67,793
-92.8%
23,955
-87.4%
0.00%
Q1 2023$935,994
-55.4%
190,630
-2.5%
0.00%
-100.0%
Q4 2022$2,099,154
-17.8%
195,452
-28.4%
0.00%0.0%
Q3 2022$2,555,000
+8.1%
272,973
+5.4%
0.00%0.0%
Q2 2022$2,364,000
-29.7%
258,875
-6.4%
0.00%0.0%
Q1 2022$3,361,000
-6.0%
276,655
-5.8%
0.00%0.0%
Q4 2021$3,577,000
+8.2%
293,696
+37.2%
0.00%0.0%
Q3 2021$3,307,0000.0%213,994
-7.7%
0.00%0.0%
Q2 2021$3,307,000
+1244.3%
231,769
+1947.4%
0.00%
Q1 2021$246,000
-92.3%
11,320
-95.1%
0.00%
-100.0%
Q3 2017$3,193,000
+55.6%
233,237
+74.9%
0.00%0.0%
Q2 2017$2,052,000
+553.5%
133,359
+164.4%
0.00%
Q1 2016$314,000
-89.9%
50,437
-72.7%
0.00%
-100.0%
Q4 2015$3,116,000
+24.1%
184,811
+5.2%
0.00%0.0%
Q3 2015$2,510,000
+41733.3%
175,664
+35970.6%
0.00%
Q2 2015$6,0004870.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 2,799,058$42,350,00022.29%
Chescapmanager LLC 1,314,603$19,890,0002.42%
Prosight Management, LP 294,041$4,449,0002.06%
DAFNA Capital Management LLC 261,442$3,956,0001.18%
Cypress Capital Management LLC (WY) 81,269$1,230,0001.06%
KINGDON CAPITAL MANAGEMENT, L.L.C. 626,583$9,480,0001.02%
Carmignac Gestion 1,851,443$28,012,0000.29%
FARALLON CAPITAL MANAGEMENT LLC 2,465,000$37,295,0000.22%
Ikarian Capital, LLC 301,700$4,565,0000.20%
DISCIPLINED GROWTH INVESTORS INC /MN 689,899$10,438,0000.20%
View complete list of CARA THERAPEUTICS INC shareholders